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Mouse hepatitis virus (MHV) is a member of the family Coronaviridae. These positive strand RNA viruses encode a replicase polyprotein that
is processed into 16 nonstructural proteins (nsps). The nsps assemble with membranes to generate double membrane vesicles, which are the sites
of viral RNA synthesis. MHV nsp3 contains multiple domains including two papain-like protease domains, PLP1 and PLP2, and a predicted
transmembrane (TM) domain. In this study, we determined the membrane topology of nsp3-TM and showed that TM-mediated tethering of PLP2
is important for processing at cleavage site 3. Biochemical analysis revealed that nsp3 is an integral membrane protein that is inserted into the
endoplasmic reticulum (ER) membranes co-translationally and glycosylated at asparagine-2357. Proteinase K digestion experiments indicate that
the TM domain of nsp3 has 4 membrane-spanning helices. We show that nsp3-TM is sufficient in mediating ER membrane association of a
cytosolic protein. This study is the first detailed analysis of the topology and function of the coronavirus nsp3 TM domain.
© 2006 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Replicase polyprotein; Papain-like protease; Transmembrane domainIntroduction
Proteolytic processing of a replicase polyprotein and the
generation of a membrane-associated replication complex are
common themes in studies analyzing the replication of positive
strand RNA viruses. For the majority of coronaviruses, the
proteolytic processing of the viral replicase polyprotein is
mediated by three distinct viral proteinases to generate 16
replicase products [reviewed in (Ziebuhr, 2005)]. Both
coronavirus and the related arterivirus replicase products
have been shown to assemble with cellular membranes to
generate double-membrane vesicles that are the sites of viral
RNA synthesis (Goldsmith et al., 2004; Gosert et al., 2002;
Pedersen et al., 1999; Snijder et al., 2006). The goal of our
research is to characterize the coronavirus replicase proteolytic
processing cascade and identify factors that mediate mem-
brane-association of the replication complex.⁎ Corresponding author. Fax: +1 708 216 9574.
E-mail address: sbaker1@lumc.edu (S.C. Baker).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.12.009Our model system is the replication of MHV, one of the
prototype coronaviruses.MHVis a∼31.5-kilobase (kb) positive-
strandRNAvirus that replicates in the cytoplasmof infected cells.
The 5′-most 22 kb of theMHV genomic RNA contains two large
open reading frames (ORFs), termed ORF1a and ORF1b (Lee et
al., 1991). During translation of the genomic RNA, the twoORFs
are joined via a ribosomal frameshifting mechanism to produce a
polyprotein of ∼800 kilodaltons (kDa) in size (Brierley et al.,
1987; Lee et al., 1991). This polyprotein is the viral RNA-
dependent RNA polymerase, termed the replicase. The MHV
replicase is processed by three distinct proteases contained within
ORF1a of the replicase polyprotein. Two of the proteases are
papain-like cysteine proteases, termed PLP1 and PLP2. The third
protease domain is distantly related to the picornavirus family of
3C-like proteases, and is termed 3CLpro. These three proteases
process the replicase polyprotein to produce intermediates and
products that function in the replication of genomic RNA and the
synthesis of a nested set of subgenomic mRNAs [reviewed in
(Brian and Baric, 2005; Sawicki and Sawicki, 2005)]. Studies
have shown that the replicase products alone are sufficient to
mediate viral RNA synthesis (Thiel et al., 2001), and to generate
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RNA synthesis (Pedersen et al., 1999). However, the role of
proteolytic processing in regulating the assembly and function of
the MHV replication complex is not yet understood. Therefore,
we wanted to identify regions of the replicase polyprotein that
may direct or regulate proteolytic processing and/or membrane
association. The focus of this study was to identify the regions of
MHV nsp3 that direct membrane association and PLP2 activity.
Previously, we showed the MHV PLP2 can act in trans to
process cleavage site 3 (CS3) at the nsp3/nsp4 junction
(Kanjanahaluethai and Baker, 2000; Kanjanahaluethai et al.,
2003). Other coronaviruses, such as the Human Coronavirus
229E, have been shown to utilize PLP2 (also termed PL2pro) to
process sites both upstream and downstream of the catalytic
domain (Ziebuhr et al., 2001). The papain-like protease (PLpro)
encoded by the coronavirus that causes severe acute respiratory
syndrome (SARS-CoV) processes three sites in the replicase
polyprotein (Harcourt et al., 2004), and has recently been shown
to have de-ubiquitinating activity (Barretto et al., 2005; Lindner
et al., 2005). The crystal structure of this enzyme has been
resolved and is currently being targeted for anti-viral drug
development (Ratia et al., 2006). A better understanding of the
coronavirus papain-like proteases may facilitate anti-viral drug
development for SARS and also other recently identified human
coronavirus infections caused by NL63 (van der Hoek et al.,
2004) andHKU1 (Woo et al., 2005), which can cause pneumonia
and respiratory tract infections in children and the elderly.
The aims of this studywere to determine the topology ofMHV
nsp3 and to identify the regions in nsp3 required for PLP2
activity. We used a trans-cleavage assay to determine if an
expressed PLP2 domain was sufficient for the recognition and
processing of a substrate containing CS3. We found that
constructs containing PLP2 and the downstream putative TM
domain were able to efficiently process the substrate. Bioinfor-
matic analysis of the nsp3-TM domain indicated the presence of
putative membrane-spanning helices and consensus sites for
N-linked glycosylation. Site-directed mutagenesis of the aspar-
agine residues and analysis of endoglycosidase H (endo H)
sensitivity revealed that asparagine-2357 in nsp3-TM is glyco-
sylated. To investigate the topology of nsp3-TM, we tested for
sensitivity to digestion with proteinase K and found that at least
two lumenal domains are protected, consistent with 4 membrane-
spanning regions in nsp3-TM.We showed that nsp3-TM alone is
sufficient to confer membrane association to a normally cytosolic
protein, enhanced green fluorescent protein (EGFP), and that a
predicted multi-spanning TM domain is conserved in nsp3 of all
coronaviruses. Thus, the nsp3-TM domain is important for
membrane association of the replicase and tethering the PLP2
domain for viral polyprotein processing activity.
Results and discussion
The MHV nsp3-TM domain is important for PLP2 processing
at cleavage site 3
Analysis of SARS-CoV PLpro activity showed that the nsp3
hydrophobic domain downstream of PLpro is essential forprocessing at CS3 (Harcourt et al., 2004). To determine if a
similar domain is important for MHV PLP2 activity, we
generated a series of PLP2 C-terminal deletion constructs and
tested each construct for expression and processing activity.
PLP2 expression constructs were generated by polymerase
chain reaction (PCR) amplification and cloning of the amplified
region into pcDNA3.1/V5-His, as described in Materials and
methods. To determine if each clone was expressing a protein of
the expected size, we analyzed the products after T7-mediated
expression and immunoprecipitation (Fuerst et al., 1986;
Kanjanahaluethai and Baker, 2000). We detected the expected
series of truncated PLP2 proteins that ranged in size from
∼96 kDa to ∼50 kDa (Fig. 1B, lanes 1–6). To determine if
these PLP2 products were sufficient to mediate processing of
CS3, we tested each construct in the trans-cleavage assay by
co-transfection with the substrate (Fig. 1C, lanes 7–12). We
found that only two of the PLP2 expression products, pPLP2–
2485 and pPLP2–2390, were able to efficiently process the
substrate and produce the 44-kDa cleavage product, nsp4 (Fig.
1C, lanes 7 and 8). These two constructs encompass all or a
major part of the predicted nsp3-TM domain indicating that
membrane tethering of PLP2 is important for recognition and
processing at CS3. Thus, both SARS-CoV PLpro (Harcourt
et al., 2004) and MHV PLP2 require the downstream TM
domain for recognition and processing at the nsp3/nsp4 junction.
Bioinformatic analysis of nsp3-TM predicts a series of putative
membrane-spanning sequences
Previously, we showed that MHV nsp3 is indeed an integral
membrane protein, but the role of the TM in mediating this
membrane association was not investigated (Gosert et al., 2002).
Initial bioinformatic analysis indicated two transmembrane
helices in nsp3 (Ziebuhr et al., 2001). To extend these studies
of membrane association of coronavirus replicase products, we
analyzed the amino acid sequence of MHV-JHM nsp3 (from
glycine-833 to glycine-2840) for probability of transmembrane
helices using the five different programs designed to search for
putative membrane-spanning sequences: Phobius, TMHMM,
HMMTOP, SOSUI and TMpred (Fig. 2). Interestingly, each
program generated a unique prediction for the topology of nsp3
(Fig. 2C). The number of predicted membrane-spanning
domains varied from three (Phobius) to seven (TMpred).
However, since both the N- and C-termini of nsp3 are cleaved
in the cytosol, the number of membrane-spanning helices must
be either two [as previously predicted (Ziebuhr et al., 2001)],
four or six. To better understand the topology of the nsp3-TM
domain, we performed membrane-association, fractionation and
proteinase K protection experiments.
Nsp3-TM is an integral membrane domain
To determine if the nsp3-TM is indeed required for
membrane association, we performed in vitro transcription
and translation of the PLP2 expression constructs in the
absence or presence of canine microsomal membrane (CMM)
and assayed for membrane association. The newly translated
Fig. 1. (A) Schematic diagram illustrating MHV-JHM ORF1a, and the PLP2 and substrate expression constructs. MHV-JHM ORF1a containing the papain-like
protease domain 1 (PLP1), the papain-like protease domain 2 (PLP2), the predicted nsp3 transmembrane domain (TM), membrane-associated nsp4, the 3C-like
protease domain (3CLpro), and membrane-associated nsp6 are designated. The genetic organization and polyprotein processing of MHV-JHM ORF1a are
schematically illustrated at top. Open arrows denote cleavage sites recognized by PLP1 or 3CLpro. Filled arrow indicates the cleavage site recognized by PLP2. The
protease activities expressed from PLP2 constructs against the nsp3TM–nsp4 substrate are summarized: +, has trans-cleavage activity; −, no detectable processing of
substrate. (B and C) Trans-cleavage activity of MHV-JHM PLP2 deletion constructs. HeLa–MHVR cells were infected with vTF7.3 and transfected with plasmid
DNA encoding an MHV-JHM PLP2 region alone (B), or co-transfected with the substrate (C). Newly synthesized proteins were labeled with [35S]-translabel from
5.5–10.5 hpi. Cell lysates were prepared and subjected to immunoprecipitation with anti-V5 antibody. Immunoprecipitated proteins were analyzed by electrophoresis
on 5.0–12.5% gradient SDS–PAGE, processed, and subjected to autoradiography. Molecular weight markers are indicated to the left.
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subjected to centrifugation to separate the membrane-asso-
ciated pelleted fraction from the soluble fraction. Protein
products of both fractions were analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE), and
visualized by autoradiography (Fig. 3). The percentage of total
proteins detected in soluble and pelleted fractions was
quantitated by phosphoimaging analysis. In the absence of
CMM, the translated protein products were detected predomi-
nantly in the soluble fraction (Fig. 3A). In contrast, whenCMMswere added to the mixture, protein products that included
all or part of nsp3-TM (PLP2–2485, –2390 and –2258) were
detected predominantly in the pelleted fraction, consistent with
membrane association (Fig. 3B). To determine if the membrane
association occurred co-translationally or post-translationally,
we added the CMMs after termination of translation, and
assessed membrane association. Previous studies with hepatitis
C virus revealed post-translational insertion of the NS5A
replicase protein (Brass et al., 2002). We found that the
translation product of PLP2–2485 is inserted co-translationally,
Fig. 2. Diagram of the probability of transmembrane helices in MHV-JHM nsp3. (A) The MHV-JHM nsp3 extends from amino acid glycine-833 to glycine-2840.
The amino acid numbering is according to NCBI accession number NC006852. Conserved domains previously identified by comparative sequence analysis (Ziebuhr
et al., 2001) and the recently described ADP-ribose-1ʺ-phosphatase (ADRP) domain (Saikatendu et al., 2005) are indicated. Two putative sites for N-linked
glycosylation were predicted at asparagine residues 2281 and 2357. (B) The diagram shows the results of an analysis of the nsp3 for predicted transmembrane helices
using TMHMM program. The predicted TM domain designates the boundaries of the putative membrane-spanning regions A, B, C, D, and E. (C) Sequence of the
PLP2–TM (amino acid residues 1610 to 2485) were analyzed for the prediction of transmembrane domains using Phobius, TMHMM, HMMTOP, SOSUI and
TMpred programs.
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(Fig. 3C). These results indicate that MHV nsp3 membrane
insertion likely occurs via the normal, signal recognition particle
(SRP)-dependent ER translocation mechanism, and not via a
tail-anchoring or post-translational mechanism.
To distinguish between membrane association versus
integral membrane insertion, membrane extraction experiments
were performed. Protein products expressed from pPLP2–2485,
pPLP2–2390 and pPLP2–2258 constructs were translated in
vitro in the presence of CMM and the pelleted fraction was
subsequently subjected to differential extraction methods as
indicated in Fig. 4. As expected, treatment with NTE buffer
alone had no effect and the proteins pelleted with membranes,
whereas treatment with detergent Triton X-100 disrupted the
membranes, and the proteins were detected in the soluble
fraction (Fig. 4A). Treatments with urea, NaCl or sodium
carbonate, pH 11.5 have been shown to disrupt the association
between peripheral, membrane-associated proteins, but suchtreatments do not disrupt integral membrane proteins (Bordier,
1981). We tested for disruption of PLP2–TM proteins and
found that majority of the proteins remained in the pelleted
membrane fraction, consistent with integral membrane proteins
(Fig. 4B). We noted that the protein product expressed from
pPLP2–2258, which contains only one or two predicted
membrane spanning helices, was dissociated by treatment
with high pH, but that the protein products expressed from
constructs that extended further into the TM were not disrupted
from the membranes by these treatments, consistent with the
characteristics of integral membrane proteins.
Bioinformatic analysis also revealed two consensus sequences
for N-linked glycosylation [the consensus being NX(T/S), where
X is any amino acid (Helenius and Aebi, 2001)] in nsp3-TM.
If one or more of the predicted sequences was indeed a
transmembrane helix, then the sites for N-linked glycosylation
could be lumenal, and subject to modification. To determine if
either of the putative sites was modified by glycosylation, we
Fig. 3. Detection of membrane association of the MHV-JHM PLP2 expressed protein products. Plasmid DNAs were linearized and subjected to in vitro transcription
and translation in the absence (A) or presence (B) of CMM, or post-translational addition of CMM (C). Proteins were labeled with [35S]-translabel, immunoprecipitated
with anti-V5 antibody, analyzed on 10% SDS–PAGE, visualized by autoradiography, and quantitated by phosphoimaging. The percentages of total protein detected in
the soluble (S) versus the pelleted (P) fraction are indicated below the gel. White bars represent proteins detected in soluble fraction, while gray bars represent proteins
detected in pellet fraction.
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(Kanjanahaluethai and Baker, 2000) and two asparagine-to-
alanine substitution mutants to endo H treatment (Fig. 5).
Expressed proteins were radiolabeled with [35S]-translabel,
lysates were prepared, and subjected to immunoprecipitation
with anti-V5 antibody as described in Materials and methods.
The PLP2–Cen protein was either untreated, or treated with
endo H for 16 h, then analyzed for mobility by electrophoresis
through a 5% polyacrylamide gel. We found that the untreated
wild-type protein migrated at approximately 110 kDa (lane 1).
However, after digestion with endo H, the protein migrated at
108 kDa (lane 2), consistent with the loss of one N-linked
modification. The PLP2–Cen–N2357A protein with an aspar-
agine-to-alanine substitution migrated more quickly than thewild type or N2281A protein, indicating that N2357 is the site
modified by N-linked glycosylation (compare lanes 3–5).
Furthermore, proteins generated by endo H treatment of the
pPLP2–Cen–N2357A and pPLP2–Cen–N2281A migrated
more quickly than wild type PLP2–Cen (lanes 6–8). These
results indicate that nsp3 is glycosylated at asparagine-2357.
Overall, these experiments demonstrate that nsp3-TM does
have transmembrane and lumen sequences that can tether the
PLP2 domain to intracellular membranes.
To further investigate the topology of nsp3-TM, we tested for
sensitivity to proteinase K digestion. Cytosolic domains are
sensitive to proteinase K, whereas transmembrane and lumenal
domains are protected from digestion with proteinase K.
Analysis of PLP2–2485 revealed two major fragments of
Fig. 4. Membrane extraction experiments of the PLP2 expressed protein products treated with Triton X-100, urea, NaCl or sodium carbonate solution pH 11.5. In vitro
transcription and translation reactions of pPLP2–2485, pPLP2–2390 or pPLP2–2258 were performed in the presence of CMM. Subsequently, reaction mixtures were
centrifuged to sediment CMM containing associated PLP2 protein. The supernatant were removed and the pellets were resuspended in NTE buffer or 0.5% Triton X-
100 (A), 4 M urea, 1 M NaCl or 100 mM sodium carbonate solution pH 11.5 (B) and incubated for 20 min at 4 °C. Subsequently, membrane sedimentation analyses
were performed as described under Materials and methods. Soluble (S) and pellet (P) fractions were applied in equivalent amounts and subjected to 12% SDS–PAGE
analysis. Quantitation was performed by phosphoimaging and values expressed in % were given at the bottom and depicted as bars.
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6, lane 2). We noted the predicted size of the TM domain from
K2227-Y2469 is 28.0 kDa, and the predicted size of the K2227-
I2308 (A and B helices) is 9.6 kDa. Analysis of PLP2–2390
revealed two protected fragments of 19 kDa and 10 kDa,
respectively (Fig. 6, lane 4). The predicted size of the K2227-
S2390 fragment is 18.8 kDa. By combining the results of the
integral membrane assays (Figs. 3 and 4), the glycosylation
assay (Fig. 5), and the proteinase K sensitivity assay (Fig. 6A),
we were able to generate a topology model for nsp3-TM that is
consistent with all the data (Figs. 6B and C). Our results indicate
that nsp3-TM has four membrane-spanning sequences and two
lumenal domains (Fig. 6B) and that the 10 kDa fragment likely
represents the proteinase K resistant fragment generated by the
first two membrane-spanning sequences. Our model is most
similar to the predicted models generated by the TMHMM and
SOSUI programs with the exception that the fourth predicted
membrane-spanning sequence (which is the only domain not
consistent in these two predictions) is not a membrane-spanning
sequence, but instead remains lumenal, and the final membrane-
spanning domain is in the reverse orientation. Our results, andFig. 5. Effect of amino acid substitution of asparagine residue 2281 or 2357 on the mi
to an alanine residue by site-directed mutagenesis as described in Materials and metho
T7 expression system, and immunoprecipitated products were analyzed by electrop
N-linked glycosylation is shown.the results of others (Hugle et al., 2001; Miller et al., 2006),
demonstrate the importance of experimental validation of
bioinformatics predictions of membrane-spanning sequences.
For example, in the case of Dengue virus type 2 nonstructural
protein 4B, Miller and co-workers found that two computer-
predicted transmembrane helices were in fact lumenal and one
was glycosylated (Miller et al., 2006). In addition, we note the
value of using multiple programs to better estimate the
complexity of the bioinformatic prediction. The differences in
the predicted models could then be tested experimentally. Here,
we provide an initial model of nsp3-TM that should be refined
by further experimentation. Similar studies should also be
performed to determine the topology of nsp4 and nsp6, the other
coronavirus replicase products with multiple predicted trans-
membrane helices.
Finally, to determine if the TM domain of MHV nsp3 was
sufficient to confer membrane association to a cytosolic protein,
we appended nsp3-TM to EGFP and determined the localiza-
tion of the fusion protein using confocal microscopy (Fig. 7).
EGFP normally is distributed throughout the cell (Fig. 7A). We
found that appending the MHV nsp3-TM sequence to EGFPgration of the PLP2–Cen protein. Asparagine residue 2281 or 2357 was changed
ds. Wild-type and mutant plasmid DNAs were expressed via the vaccinia virus–
horesis on 10% SDS–PAGE. The effect of treatment with endo H to remove
Fig. 6. Digestion of the PLP2–TM translation products with proteinase K. Cell-free transcription and translation assay of either linearized pPLP2–2485 or pPLP2–
2390 in the presence of CMM were performed as described in Materials and methods. Proteins were labeled with [35S]-translabel for 90 min, and then treated with
proteinase K for 30 min. The digested products were analyzed on 15% SDS–PAGE, and subjected to autoradiography. (B) The proposed model of proteinase K
protection to PLP2–2485 translation product. Arrowheads depict potential proteinase K cleavage sites. The tree symbol ( ) represents the experimentally confirmed
N-linked glycosylation site of asparagine at position 2357. The putative membrane-spanning regions A, B, C, D, and E of the nsp3 TM domain are depicted by gray
circles. (C) The proposed model of PK protection of PLP2–2390 translation product.
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intense, perinuclear localized signal (Fig. 7B). To determine if
the nsp3-TM domain is retained in the ER membranes or is
transported through the medial Golgi, we radiolabeled the
EFGP–nsp3TM protein in transfected cells, immunoprecipi-
tated the protein and subjected the immunoprecipitated products
to endo H. We found that EFGP–nsp3TM is sensitive to
treatment with endo H, indicating that the protein is retained in
the ER and does not pass through the medial Golgi. Thus, the
nsp3-TM domain is sufficient to confer membrane-localization
and retention in the ER. These studies are in agreement with our
previous findings showing that the TM domain of SARS-CoV
nsp3 (previously termed the HD) confers membrane association
of EGFP (Harcourt et al., 2004).
In summary, using biochemical fractionation and protei-
nase K protection assays, we show that nsp3-TM likely has
four membrane-spanning domains, and that lumenal residue
asparagine-2357 is modified by glycosylation. Furthermore,
we found the region nsp3-TM domain is required for efficient
MHV PLP2 process activity at cleavage site 3 in the
polyprotein. Why does MHV PLP2 require membrane
association for proteolytic processing of the PLP2 cleavage
site? One possible explanation is that membrane-tethering
brings PLP2 into close proximity with a membrane-associated
substrate. It is also possible that the nsp3-TM membranetether is important for anchoring the replicase complex to
intracellular membranes. Bioinformatic analysis of the nsp3 of
10 other coronaviruses revealed that the membrane-spanning
features of nsp3-TM are conserved in all viruses (Fig. 8,
analysis using the TMHMM program is shown as an
example), even though the amino acid identity is relatively
low (18–32% identity within nsp3). Therefore, the TM
domain is likely to be important for both PLP2 activity and
assembly of the replication complex. Further studies will be
required to determine the precise topology of the TM domain
in other coronaviruses, and if the lumenal sequences in nsp3-
TM play any role in interacting with host factors during viral
replication.
Materials and methods
Cells
HeLa cells expressing the MHV receptor, HeLa–MHVR
cells (Gallagher, 1996) were used for all transfection experi-
ments. The cells were grown in Dulbecco's modified Eagle's
medium supplemented with 10% fetal bovine serum (Invitro-
gen, Carlsbad, CA), 0.5% penicillin/streptomycin, 2% gluta-
mine, and 5 mM sodium N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid, pH 7.4.
Fig. 7. Detection of EGFP from transfected cells. HeLa–MHVR cells were transfected with either pEGFP (A) or pEGFP–nsp3TM (MHV-JHM amino acid alanine-
2228 to valine-2478) (B) for 48 h. Then cells were washed, and visualized by confocal microscopy. (C) EFGP–nsp3TM was cloned into the pcDNAV5His expression
vector and plasmid DNA was expressed via the vaccinia virus–T7 expression system and immunoprecipitated with anti-V5. Immunoprecipitated products were
incubated in the presence or absence of endo H and analyzed by electrophoresis on 10% SDS–PAGE.
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Recombinant plasmid DNA constructs expressing the PLP2
coding region were generated using specific primers (listed in
Table 1) to amplify the designated region from the parental
plasmid pPLP2–Cen (Kanjanahaluethai and Baker, 2000). The
region of interest was generated by PCR amplification using LA-
Taq polymerase according to the manufacturer's instructions
(Clontech, Palo Alto, CA). The amplified region was then
digested with restriction enzymes BamHI and XhoI and ligated
into the corresponding sites in the pcDNA3.1/V5-His expression
vector (Stratagene, La Jolla, CA) using T4 ligase (New England
Biolabs). The ligated DNA product was transformed into XL-1
Blue competent cells according to the manufacturer's instructions
(Stratagene), except that the bacteria were grown at 25 °C.
PLP2 trans-cleavage assay
HeLa–MHVR cells were infected with a recombinant
vaccinia virus expressing the bacteriophage T7 polymerase
(vTF7-3) at a multiplicity of infection of 10. Then, infected cells
were co-transfected with recombinant plasmid DNAs encoding
the MHV-JHM indicated protease domain and the substrate
using lipofectamine according to manufacturer's instruction as
previously described (Fuerst et al., 1986; Kanjanahaluethai and
Baker, 2000). Newly synthesized proteins were metabolically
labeled with 50 μCi/ml [35S]-translabel (ICN, Costa Mesa, CA)
from 5.5 to 10.5 h post-infection (hpi). To harvest the cells,
radioactive labeled cells were washed with phosphate bufferedsaline (PBS), and cell lysates were prepared by scraping the
cells in lysis buffer A [4% SDS, 3% DTT, 40% glycerol and
0.065 M Tris, pH 6.8 (Schiller et al., 1998)]. The lysates were
either used directly for immunoprecipitation assays or stored at
−70 °C for future studies.
Radioimmunoprecipitation assays
Radiolabeled cell lysate was diluted in 1.0 ml RIPA buffer
[0.5% Triton X-100, 0.1% SDS, 300 mM NaCl, 4 mM EDTA,
and 50 mM Tris–HCl, pH 7.4 (Schiller et al., 1998)] and
subjected to immunoprecipitation with anti-V5 monoclonal
antibody (Invitrogen) and protein-A sepharose beads (Amer-
sham Biosciences, Piscataway, NJ). The immunoprecipitated
products were eluted with 2× Laemmli sample buffer, incubated
at 30 °C for 30 min, and analyzed by electrophoresis on a 5.0–
12.5% gradient polyacrylamide gel containing 0.1% SDS.
Following electrophoresis, the gel was fixed in 25% methanol–
10% acetic acid, enhanced with Amplify (Amersham Bio-
sciences) for 60 min, dried, and exposed to Kodak X-ray film at
−70 °C.
Site-directed mutagenesis of putative glycosylation sites in
MHV-JHM nsp3-TM domain
Plasmid DNA pPLP2–Cen which encompasses MHV-JHM
gene 1 amino acid residues 1525–2485 (Kanjanahaluethai and
Baker, 2000) was subjected to site-directed mutagenesis at
positions 7055 and 7056 for pPLP2–N2281A and positions
Fig. 8. Diagram of the probability analysis of transmembrane helix domains in nsp3 of 10 coronaviruses using the TMHMM program. NCBI accession numbers are as
follows: Human coronavirus (HCoV) 229E, NC_002645 (nt 2984–7744); HCoV-NL63, NC_005831 (nt 2981–7672); HCoV-HKU1, NC006577 (nt 2633–8719);
SARS-CoV (Urbani), AY278741 (nt 2719–8484); HCoV-OC43, NC_005147 (nt 2764–8460); bovine coronavirus (BCoV), NC_003045 (nt 2764–8460);
transmissible gastroenteritis virus of pigs (TGEV), NC_002306 (nt 2952–7478); feline coronavirus (FCoV), AY994055 (nt 2948–7549); infectious bronchitis virus of
chickens (IBV), NC_001451 (nt 2548–7323); murine coronavirus strain MHV-A59, NC_001846 (nt 2706–8720). All these coronavirus genomes are available at the
NIH sponsored Pathogen Resource Integration Center, PATRIC, at www.patric.vbi.vt.edu.
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Table 1
Primers used for amplification or mutagenesis of MHV-JHM sequences
Construct name Primer Oligonucleotide sequence (5′ to 3′) a Nucleotide number b Polarity
pPLP2–2485 B244 GGGGATCCAGGATGGTTGATGTCTTGTGTA 5042–5057 Forward
B205 CCCTCGAGCCAGGCTTACTACATCCATA 7652–7671 Reverse
pPLP2–2390 B258 AACTCGAGGACACACGCCTATCTAC 7367–7383 Reverse
pPLP2–2258 B345 TTCTCGAGGCTTTCGCTTTGACCAC 6881–6897 Reverse
pPLP2–2224 B346 GCCTCGAGGACATACCCCACTTAAC 6797–6813 Reverse
pPLP2–2200 B327 GGCTCGAGACTTCTGTGGTGTATAT 6977–6993 Reverse
pPLP2–2155 B257 GGCTCGAGACTTTGGTTTCGCTAGTG 6661–6678 Reverse
pEGFP–nsp3TM B410 AACTCGAGCTATTGCCTGCTTAG 6896–6911 Forward
B411 AAGGATCCAACATGTCTACAAAGACAATAGAC 7625–7648 Reverse
pcEGFP–nsp3TM ZCP1 AAGGATCCGTCGCCACCATGGTGAGCAAGGGC EGFP Forward
ZCP2 AATCTAGACTAACATGTCTACAAAGACAATAGAC 7625–7648 Reverse
Site-directed mutants c Amino acid changed
B341 GAATGCCTTACAGACGTTTGCTTGGAGCGTTG TGTCTAGGGG 7036–7077 N2281A
B343 GGCTATAGGAGTTCGTTTTGTGCTGGAAGTATGGTCTGTGAAC 7262–7304 N2357A
a Underlined sequences were required for cloning, expression of MHV sequences or mutagenesis.
b MHV-JHM nucleotide numbers are according to NCBI accession number NC006852.
c Sequence of one primer of each complementary primer pair is shown.
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cleotides with mismatches encoding specific nucleotides
changes as shown in Table 1. Mutagenesis was performed
according to the manufacturer's instructions (QuickChange
Site-Directed Mutagenesis; Stratagene), and as previously
described (Kanjanahaluethai and Baker, 2000). Mutations
were confirmed by DNA sequence analysis.
In vitro transcription and translation
The TNT T7-coupled reticulocyte lysate system (Promega,
Madison, WI) was used according to the manufacturer's
instructions. The recombinant plasmid DNA encoding the
designated PLP2 region was linearized by digestion with
PmeI. In vitro transcription and translation was performed for
90 min at 30 °C in the presence of 0.8 μCi of [35S]-translabel
per ml in a volume of 25 μl. Where indicated, 1.0 μl of CMM
(Promega) was added prior to the incubation. For analysis of
membrane association, the products of in vitro transcription
and translation were centrifuged at 14,000 rpm for 10 min.
The supernatant was removed, the pellet that may contain
aggregated or membrane-associated protein was suspended in
2× Laemmli sample buffer, heated at 95 °C for 5 min, and
both fractions were analyzed by SDS–PAGE and subjected to
autoradiography.
Proteinase K protection assay
Protection of translation products by microsomal membranes
was examined by digestion with proteinase K (Hugle et al.,
2001). Following translation, reaction mixtures (after incuba-
tion with RNase A) were adjusted to 0.5 mg/ml of proteinase K
(Roche, Indianapolis, IN) and incubated for 30 min on ice.
Proteinase K digestion was terminated by addition of
phenylmethylsulfonyl fluoride to 1 mg/ml and incubation was
continued for 5 min on ice. A portion of each reaction mixture
(generally 4 μl) was mixed with 40 μl of 2× Laemmli samplebuffer, heated at 95 °C for 5 min, analyzed by 15% SDS–PAGE
and subjected to autoradiography.
Endoglycosidase H treatment
For endo H treatment, lysates from vTF7.3-infected and
pPLP2–TM transfected cells were prepared and subjected to
immunoprecipitation as described above. Protein-A sepharose–
antibody–antigen complexes were washed once in RIPA buffer
and endo H treatment was performed as suggested by the
manufacturer (Roche). Briefly, the complexes were resuspended
in 20 μl of 50 mM sodium phosphate buffer, pH 6.0, and
incubated in the presence or absence of a final concentration of
1 unit/μl of endo H for 16 h at 37 °C. Following the incubation,
25 μl of 2× Laemmli sample buffer was added to each sample,
mixed, and incubated for 30 min at 37 °C. The sepharose beads
were pelleted by a brief, high-speed spin in a microfuge, and the
supernatant loaded directly for analysis by 12% SDS–PAGE
and subjected to autoradiography.
Determining membrane association
For membrane extraction experiments, the pellets from 15 μl
in vitro transcription–translation reactions performed in the
presence of CMM were resuspended in 40 μl NTE buffer, 0.5%
Triton X-100, 4 M urea, 1 M NaCl, or 100 mM sodium
carbonate (pH 11.5) and incubated for 20 min at 4 °C (Hugle
et al., 2001). Subsequently, supernatant and pellet fractions
were separated by centrifugation at 14,000 rpm for 10 min, and
analyzed by SDS–PAGE and autoradiography. Quantitation
was performed by using phosphoimaging analysis.
Expression of EGFP–nsp3TM
The putative transmembrane domain 1 region of MHV-JHM
nsp3 (nt 6896 to 7648) was PCR amplified from the pPLP2–
Cen (Kanjanahaluethai and Baker, 2000) with primers B410
401A. Kanjanahaluethai et al. / Virology 361 (2007) 391–401and B411 (Table 1), cloned into the mammalian expression
vector for EGFP, pEGFP-C1 (BD Biosciences), and designated
pEGFP–nsp3TM. The plasmid DNA encoding EGFP or
EGFP–nsp3TM was transfected into HeLa–MHVR cells in 8-
well chamber culture slides with lipofectamine according to
manufacturer's instructions, for 48 h. Expression of EGFP and
EGFP–nsp3TM fusion protein products was detected by
confocal microscopy (Zeiss LSM 510 lazer-scanning confocal
microscope). EGFP–nsp3TM was amplified by primers ZCP1
and ZCP2 (Table 1) using pEGFP–nsp3TM as template, and
then cloned into BamHI and XbaI sites of pcDNA3.1/V5-HisB
(Invitrogen) to generate the construct of pcDNA3.1–EGFP–
nsp3TM. The plasmid DNA was expressed via the vaccinia
virus–T7 expression system, proteins radiolabeled with 35S-
translabel, cell lysates were subjected to immunoprecipitation
with anti-V5 antibody, and products were either incubated with
endo H or buffer alone, and analyzed by electrophoresis on 10%
SDS–PAGE.
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